logo
Search…
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Search...
search
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Home > Latest

Hongyuan Pharmaceutical: has completed the preparation of kilograms of sulfide electrolyte precursor and electrolyte samples.

date
08/02/2026
On October 31st, Hongyuan Pharmaceuticals stated on the interactive platform that the company has recently completed the preparation of kilogram-scale sulfide electrolyte precursors and electrolyte samples, and is now working on optimizing the testing of solid-state electrolytes.
Latest
3 m ago
South African Reserve Bank Governor: South Africa is eager to receive the European Central Bank's new repo loan arrangement.
1 h ago
Su Yiming won the first medal for the Chinese delegation at the Milan Winter Olympics.
1 h ago
Insiders: The Federal Communications Commission is investigating whether the ABC program "Viewpoint" violated the equal time rule by interviewing a candidate for the Texas State Senate.
1 h ago
The CEO of American Airlines has agreed to meet with the Allied Pilots Association.
2 h ago
American telemedicine company Hims & Hers Health: Since launching its customized oral formulation of Sermorelin on its platform, the company has engaged in constructive communication with various stakeholders in the industry. The company has decided to discontinue providing services related to this therapy.
See all latestmore
logo
Contact US
qr
+852 - 60190728
gmteight@futurecultural.com
Customer Support
About Us
Contact Us
Frequently Asked
Privacy Policy
Terms of Use
Commercial Services
Advertising
Business Development
Copyright
Terms of Service
©️2013 - 2026 GMT EIGHT Holdings. All Rights Reserved.